ImmuCell Corporation (ICCC) support and resistance · rev $17.5M
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
This page maps ImmuCell Corporation (ICCC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
ICCC currently screens at market cap $58.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ICCC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ICCC quote page for the session range and the stock page for the full model.
Not investment advice.